Rigel Pharmaceuticals Inc., of South San Francisco, promoted Raul R. Rodriguez to president, Dolly Vance to general counseland executive vice president of corporate affairs and Ryan Maynard to executive vice president and chief financial officer...TheraQuest Biosciences Inc., of Blue Bell, Pa., appointed Danny Kao senior vice president of pharmaceutical development andgeneral counsel, and named Douglas R. Baum senior vice president of business development
Delcath Systems Inc., of New York, appointed Peter J. Graham executive vice president andgeneral counsel...Qiagen NV, of Venlo, the Netherlands, appointed Pia Garguilo and Richard Watts to its pharma business development team
IGEN Networks Corp., of Las Vegas, appointed Monty Ormsby president and Michael Grudman chief financial officer and secretary...Sucampo Pharmaceuticals Inc., of Bethesda, Md., appointed Thomas J. Knapp senior vice president, general counseland corporate secretary
Micromet Inc., of Bethesda, Md., appointed Jan Fagerberg senior vice president and chief medical officer...MorphoSys AG, of Martinsried, Germany, appointed Lisa Rojkjaer vice president and head of clinical development...and promoted David Dodds to president of Sucampo Pharma Europe Ltd
Dyax Corp., of Cambridge, Mass., appointed Ivana Magovcevic-Liebisch executive vice president of corporate development andgeneral counsel...Quanterix Corp., of Cambridge, Mass., appointed David Okrongly CEO and a member of the company's board of directors
Richmond, Calif., appointed Joseph T. Kennedy vice president, general counseland secretary...Dafna Cohen and Yaron Diament were appointed external directors
Pluristem Therapeutics Inc., of New York, appointed Frida Grynspan vice president of research and development...PDL BioPharma Inc., of Incline Village, Nev., appointed Christopher L. Stone vice president, general counseland secretary
It also named Chas Bountra as chairman and Annette Dolphin to its scientific advisory board...and Faith Pomeroy-Ward as executive director of investor relations and corporate communications
MediGene AG, of Martinsried, Germany, said Thomas Strüngmann and Mathias Albert Boehringer were elected as new supervisory board members...Momenta Pharmaceuticals Inc., of Cambridge, Mass., appointed Bruce A. Leicher senior vice president andgeneral counsel
Ikonysis, of New Haven, Conn., named Louise Mawhinney senior vice president and chief financial officer...PharmAthene Inc., of Annapolis, Md., appointed Jordan P. Karp senior vice president andgeneral counsel
It also named Guido Magni to its board and the governance and nominating committee...Affymax Inc., of Palo Alto, Calif., promoted Robert F. Venteicher to senior vice president of technical operations and Grace U. Shin to general counsel
Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Georges Gemayel, CEO and member of the board...Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Raymond T. Keane vice president, general counseland chief compliance officer
Aegera Therapeutics Inc., of Montreal, appointed Jeremy Curnock Cook and Gary Littlejohn to its board...Cephalon Inc., of Frazer, Pa., appointed Jerry Pappert executive vice president andgeneral counsel
Medivation Inc., of San Francisco, appointed Michele D. Bronson vice president, regulatory and quality...Microbia Inc., of Cambridge, Mass., appointed Halley Gilbert vice president, general counsel
Jim Sulat, the previous president and CEO, will be chief financial executive on a part-time basis...Perlegen Sciences, of Mountain View, Calif., named Kevin Cooksy vice president of business development, appointed Julie Brooks general counseland corporate secretary and named Brenda Rogers vice president of human resources
KaloBios Pharmaceuticals Inc., of Palo Alto, Calif., named Carol Stratford general counseland head of intellectual property and Charles Democko vice president of regulatory affairs and quality
Rigel Pharmaceuticals Inc., of South San Francisco, promoted Raul R. Rodriguez to president, Dolly Vance to general counsel and executive vice president of corporate affairs and Ryan Maynard to executive vice president and chief financial officer...TheraQuest Biosciences Inc., of Blue Bell, Pa., appointed Danny Kao senior vice president of pharmaceutical development and general counsel, and named Douglas R. Baum senior vice president of business development